Blood-brain barrier penetration of cefepime after neurosurgery

被引:0
作者
WANG Jiang-fei WANG Qiang ZHAO Li-hong SHI Guang-zhi ZHOU Jian-xin Department of Neurosurgery ICU Beijing Tiantan Hospital
机构
关键词
cefepime; blood-brain barrier; drug concentration; high-pressure liquid chromatography;
D O I
暂无
中图分类号
R651 [头部及神经外科学]; R96 [药理学];
学科分类号
1002 ; 100210 ; 100602 ; 100706 ;
摘要
Background It has been confirmed that the concentration of cefepime in cerebrospinal fluid(CSF)could reach the 10%of its concentration in plasma,exceeding the inhibitory concentration to 90% of organisms(MIC9o)for common bacteria.However,the blood-brain barrier(BBB)penetration ability of cefepime is still unclear.The aim of this study was tomeasure the CSF concentration of cefepime in patients after neurosurgical operations,and to determine the penetrationof the drug through an incomplete BBB.Methods Eight patients who received ventricular drainage(VD group)and 5 who underwent lumbar puncture drainage(LPD group)were enrolled into this study.Cefepime(2 g)was injected intravenously in 30 minutes after theneurosurgeries.The concentrations of cefepime in the CSF and plasma were measured by high-pressure liquidchromatography(HPLC)at different time points.Results The CSF concentrations of cefepime at different time points in the VD group were significantly higher thanthose in the LPD group(P<0.05).In the VD group,the concentration of cefepime in CSF reached the peak((22.544.06)μg/ml)at 1 to 2 hours after the injection,while in the LPD group at 4 hours((5.61±3.73)μg/ml).In both groups,the peakwas higher than the MICof most common bacteria in intensive care unit.The ratio of CSF to plasma cefepimeconcentrations ranged from 0.30 to 2.14 in the VD group and 0.03 to 1.14 in the LPD group.Conclusion After neurosurgeries,CSF concentration of cefepime can reach a therapeutic level.Thus,the drug couldbe used to prevent and treat postoperative intracranial infection.Chin Med J 2007;120(13):1176-1178
引用
收藏
页码:1176 / 1178
页数:3
相关论文
共 7 条
  • [1] 第四代头孢菌素头孢吡肟与5种β-内酰胺类体外抗菌活性比较
    朱家馨
    唐英春
    陈瑞
    张扣兴
    谈淑卿
    [J]. 中国新药杂志, 1999, (04) : 24 - 26
  • [2] Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies
    Lodise, TP
    Rhoney, DH
    Tam, VH
    McKinnon, PS
    Drusano, GL
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (03) : 223 - 230
  • [3] Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001)[J] . Ronald N. Jones,Helio S. Sader,Mondell L. Beach. International Journal of Antimicrobial Agents . 2003 (6)
  • [4] Effect of cyclosporine, a P-glycoprotein inhibitor, on the pharmacokinetics of cefepime in rat blood and brain[J] . Yuh-Lih Chang,Mei-Hui Chou,Ming-Fang Lin,Chieh-Fu Chen,Tung-Hu Tsai. Life Sciences . 2001 (2)
  • [5] Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion
    Burgess, DS
    Hastings, RW
    Hardin, TC
    [J]. CLINICAL THERAPEUTICS, 2000, 22 (01) : 66 - 75
  • [6] Rapid high-performance liquid chromatographic determination of cefepime in human plasma
    Calahorra, B
    Campanero, MA
    Sádaba, B
    Azanza, JR
    [J]. BIOMEDICAL CHROMATOGRAPHY, 1999, 13 (04) : 272 - 275
  • [7] Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means[J] . Robert A. Kroll,Edward A. Neuwelt. Neurosurgery . 1998 (5)